In the Innovation Journal Club (IJC) series on Eyetube.net, host I. Paul Singh, MD, of The Eye Centers of Racine & Kenosha in Wisconsin, interviews leading experts from across eye care subspecialties about emerging innovations and technologies that may prove influential to the real-world practice of ophthalmology. The series is editorially independent (supported by advertising from multiple companies), which allows the discussions to be broad in scope and candid in presentation.
The following is a summary of three episodes in which Dr. Singh spoke with Sahar Bedrood, MD, PhD, about changes in MIGS reimbursement and how they affect procedural selection; Julie Schallhorn, MD, MS, about advancements in monofocal IOL technology; and Carl D. Regillo, MD, FACS, FASRS, about the emergence of second-generation anti-VEGF drugs for the treatment of age-related macular degeneration (AMD).
